Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Suda

Showing results (181-190 of 392) with videos related to

Pageof 40
Sort By:
JAMA Network Open|September 15, 2020
Comparison of Cardiac Events Associated With Azithromycin vs AmoxicillinHaridarshan Patel, Gregory S Calip, Robert J DiDomenico, et al.
Inflammatory Bowel Diseases|March 22, 2018
Risk of Serious Bacterial Infection Associated With Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Inflammatory Bowel DiseaseWan-Ju Lee, Todd A Lee, Gregory S Calip, et al.
Current Medical Research and Opinion|May 24, 2007
High- versus low-dose fluconazole therapy for empiric treatment of suspected invasive candidiasis among high-risk patients in the intensive care unit: a cost-effectiveness analysisHua Chen, Katie J Suda, Robin S Turpin, et al.
Pharmacotherapy|October 26, 2016
Use of Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Juvenile Idiopathic Arthritis or Rheumatoid ArthritisWan-Ju Lee, Leslie Briars, Todd A Lee, et al.
Experimental Hematology|May 1, 1988
Bipotential murine hemopoietic cell line (NFS-60) that is responsive to IL-3, GM-CSF, G-CSF, and erythropoietinK Hara, T Suda, J Suda, et al.
Inflammatory Bowel Diseases|August 19, 2016
Top-down Versus Step-up Prescribing Strategies for Tumor Necrosis Factor Alpha Inhibitors in Children and Young Adults with Inflammatory Bowel DiseaseWan-Ju Lee, Leslie Briars, Todd A Lee, et al.
Journal of Trauma Management & Outcomes|July 23, 2014
PHTLS ® (Prehospital Trauma Life Support) provider courses in Germany - who takes part and what do participants think about prehospital trauma care training?Christian B Frank, Christoph G Wölfl, Aidan Hogan, et al.
JAMA Network Open|January 18, 2023
Analysis by Gender and Race and Ethnicity of Reviewers and Awardees for Intramural Research Funding in the Veterans Health AdministrationTaylor L Boyer, Utibe R Essien, Terrence M A Litam, et al.
Pharmacotherapy|December 24, 2019
Prevalence of Cardiac Risk Factors in Patients Prescribed Azithromycin before and after the 2012 FDA Warning on the Risk of Potentially Fatal Heart RhythmsHaridarshan Patel, Gregory Sampang Calip, Robert J DiDomenico, et al.
Rheumatology (Oxford, England)|April 22, 2017
Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritisWan-Ju Lee, Todd A Lee, Katie J Suda, et al.
Pageof 40

Showing results (181-190 of 392) with videos related to

Sort By:
Pageof 40
JAMA Network Open|September 15, 2020
Comparison of Cardiac Events Associated With Azithromycin vs AmoxicillinHaridarshan Patel, Gregory S Calip, Robert J DiDomenico, et al.
Inflammatory Bowel Diseases|March 22, 2018
Risk of Serious Bacterial Infection Associated With Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Inflammatory Bowel DiseaseWan-Ju Lee, Todd A Lee, Gregory S Calip, et al.
Current Medical Research and Opinion|May 24, 2007
High- versus low-dose fluconazole therapy for empiric treatment of suspected invasive candidiasis among high-risk patients in the intensive care unit: a cost-effectiveness analysisHua Chen, Katie J Suda, Robin S Turpin, et al.
Pharmacotherapy|October 26, 2016
Use of Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Juvenile Idiopathic Arthritis or Rheumatoid ArthritisWan-Ju Lee, Leslie Briars, Todd A Lee, et al.
Experimental Hematology|May 1, 1988
Bipotential murine hemopoietic cell line (NFS-60) that is responsive to IL-3, GM-CSF, G-CSF, and erythropoietinK Hara, T Suda, J Suda, et al.
Inflammatory Bowel Diseases|August 19, 2016
Top-down Versus Step-up Prescribing Strategies for Tumor Necrosis Factor Alpha Inhibitors in Children and Young Adults with Inflammatory Bowel DiseaseWan-Ju Lee, Leslie Briars, Todd A Lee, et al.
Journal of Trauma Management & Outcomes|July 23, 2014
PHTLS ® (Prehospital Trauma Life Support) provider courses in Germany - who takes part and what do participants think about prehospital trauma care training?Christian B Frank, Christoph G Wölfl, Aidan Hogan, et al.
JAMA Network Open|January 18, 2023
Analysis by Gender and Race and Ethnicity of Reviewers and Awardees for Intramural Research Funding in the Veterans Health AdministrationTaylor L Boyer, Utibe R Essien, Terrence M A Litam, et al.
Pharmacotherapy|December 24, 2019
Prevalence of Cardiac Risk Factors in Patients Prescribed Azithromycin before and after the 2012 FDA Warning on the Risk of Potentially Fatal Heart RhythmsHaridarshan Patel, Gregory Sampang Calip, Robert J DiDomenico, et al.
Rheumatology (Oxford, England)|April 22, 2017
Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritisWan-Ju Lee, Todd A Lee, Katie J Suda, et al.
Pageof 40